Clinical evaluation of natalizumab for formulary consideration.
Bivins A, Hou K, Ayesu N, Ellsworth B Jr, Montenegro S, Tu X, Boyle C, Dowling T, Shaya FT.
Bivins A, et al. Among authors: dowling t.
Expert Opin Biol Ther. 2010 Aug;10(8):1279-87. doi: 10.1517/14712598.2010.505234.
Expert Opin Biol Ther. 2010.
PMID: 20626228
Review.